United States Environmental Protection Agency
Integrated Risk Information System Logo


Propargyl alcohol
CASRN 107-19-7

Contents


0468
Propargyl alcohol; CASRN 107-19-7  


Health assessment information on a chemical substance is included in IRIS only 
after a comprehensive review of chronic toxicity data by U.S. EPA health 
scientists from several Program Offices and the Office of Research and 
Development.  The summaries presented in Sections I and II represent a 
consensus reached in the review process.  Background information and 
explanations of the methods used to derive the values given in IRIS are 
provided in the Background Documents. 


STATUS OF DATA FOR  Propargyl alcohol

File On-Line 11/01/1990

Category (section)                           Status      Last Revised
-----------------------------------------    --------    ------------

Oral RfD Assessment (I.A.)                   on-line       01/01/1994

Inhalation RfC Assessment (I.B.)             no data     

Carcinogenicity Assessment (II.)             no data     



_I. CHRONIC HEALTH HAZARD ASSESSMENTS FOR NONCARCINOGENIC EFFECTS __I.A. REFERENCE DOSE FOR CHRONIC ORAL EXPOSURE (RfD) Substance Name -- Propargyl alcohol CASRN -- 107-19-7 Last Revised -- 01/01/1994 The oral Reference Dose (RfD) is based on the assumption that thresholds exist for certain toxic effects such as cellular necrosis. It is expressed in units of mg/kg-day. In general, the RfD is an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime. Please refer to the Background Document for an elaboration of these concepts. RfDs can also be derived for the noncarcinogenic health effects of substances that are also carcinogens. Therefore, it is essential to refer to other sources of information concerning the carcinogenicity of this substance. If the U.S. EPA has evaluated this substance for potential human carcinogenicity, a summary of that evaluation will be contained in Section II of this file. ___I.A.1. ORAL RfD SUMMARY Critical Effect Experimental Doses* UF MF RfD -------------------- ----------------------- ----- --- ---------- Renal and hepato- NOAEL: 5 mg/kg/day 3000 1 2E-3 toxicity mg/kg/day LOAEL: 15 mg/kg/day Rat Oral Subchronic Study U.S. EPA, 1987
*Conversion Factors: Actual dose tested ___I.A.2. PRINCIPAL AND SUPPORTING STUDIES (ORAL RfD) U.S. EPA. 1987. Rat oral subchronic toxicity study with propargyl alcohol. Study conducted by the Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC. Four groups of male and female rats (30/sex/group) were dosed orally with 0, 5, 15, and 50 mg/kg of propargyl alcohol daily for 13 weeks. The first 10 rats of each group were sacrificed on days 28-29 after dosing and the remaining rats were sacrificed on days 91 or 92 after dosing. Parameters examined included body and organ weight changes, food consumption, and hematological and histopathological evaluations. Treatment-related mortality was reported in the 50-mg/kg dosage group, although the precise cause was not identified. Hepatocytic megalocytosis with a less prominent proliferation of the bile ducts and cytoplasmic vacuolation of hepatocytes was observed in all rats in the 50 mg/kg group dosed for 1 or 3 months, in all 15 mg/kg rats dosed for 3 months, and in 9/10 males and 5/10 females dosed for 1 month. In the low-dose group, megalocytosis was seen only in one rat treated for 3 months. Karyomegaly of renal tubular epithelial cells was reported to occur in a dose- response fashion in the mid- and high-dose groups, but not in the low-dosage group. Hematological changes and some enzyme changes characteristic of liver damage were seen in the mid- and high-dose animals and were considered to be treatment-related. Treatment-related effects at the 15 mg/kg/day dose level included increased liver weights in both genders, increased kidney weights in females, and megalocytosis of the liver after 4 and 13 weeks of dosing; this dose is considered a LOAEL. The daily oral administration of 5 mg/kg of propargyl alcohol produced no apparent treatment-related effects and is considered the NOAEL for this study. ___I.A.3. UNCERTAINTY AND MODIFYING FACTORS (ORAL RfD) UF -- An uncertainty factor of 3000 was used: 10 for interspecies conversion, 10 for intraspecies sensitivity differences, 10 for subchronic study use for chronic RfD derivation and 3 for the lack of toxicity data in a second species and reproductive/developmental studies. MF -- None ___I.A.4. ADDITIONAL COMMENTS (ORAL RfD) No other chronic, subchronic, or developmental/reproductive toxicity studies were found in the literature. ___I.A.5. CONFIDENCE IN THE ORAL RfD Study -- Medium Data Base -- Low RfD -- Low The critical study identified both a NOAEL and a LOAEL for multiple endpoints and is considered to be of medium confidence. Confidence in the data base is low due to the lack of supporting subchronic, chronic, and reproductive/developmental studies. Low confidence in the RfD follows. ___I.A.6. EPA DOCUMENTATION AND REVIEW OF THE ORAL RfD Source Document -- This assessment is not presented in any existing U.S. EPA document. Other EPA Documentation -- U.S. EPA, 1987 Agency Work Group Review -- 02/21/1990 Verification Date -- 02/21/1990 ___I.A.7. EPA CONTACTS (ORAL RfD) Please contact the Risk Information Hotline for all questions concerning this assessment or IRIS, in general, at (513)569-7254 (phone), (513)569-7159 (FAX) or RIH.IRIS@EPAMAIL.EPA.GOV (internet address).
__I.B. REFERENCE CONCENTRATION FOR CHRONIC INHALATION EXPOSURE (RfC) Substance Name -- Propargyl alcohol CASRN -- 107-19-7 Not available at this time.
_II. CARCINOGENICITY ASSESSMENT FOR LIFETIME EXPOSURE Substance Name -- Propargyl alcohol CASRN -- 107-19-7 This substance/agent has not undergone a complete evaluation and determination under US EPA's IRIS program for evidence of human carcinogenic potential.
_VI. BIBLIOGRAPHY Substance Name -- Propargyl alcohol CASRN -- 107-19-7 Last Revised -- 01/01/1994 __VI.A. ORAL RfD REFERENCES U.S. EPA. 1987. Rat oral subchronic toxicity study with propargyl alcohol. Study conducted by the Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC.
__VI.B. INHALATION RfC REFERENCES None
__VI.C. CARCINOGENICITY ASSESSMENT REFERENCES None
_VII. REVISION HISTORY Substance Name -- Propargyl alcohol CASRN -- 107-19-7 -------- -------- -------------------------------------------------------- Date Section Description -------- -------- -------------------------------------------------------- 11/01/1990 I.A. Oral RfD summary on-line 11/01/1990 VI. Bibliography on-line 01/01/1992 IV. Regulatory Action section on-line 07/01/1993 I.A.6. Other EPA Documentation added 01/01/1994 I.A.1. Citation year changed to 1987 01/01/1994 I.A.2. Citation year changed to 1987 01/01/1994 I.A.6. Citation year changed to 1987 01/01/1994 VI.A. Reference year changed to 1987
VIII. SYNONYMS Substance Name -- Propargyl alcohol CASRN -- 107-19-7 Last Revised -- 11/01/1990 107-19-7 2-Propyn-1-ol Ethynylcarbinol HSDB 6054 METHANOL, ETHYNYL- NA 1986 NSC 8804 Propargyl alcohol PROPYNYL ALCOHOL RCRA WASTE NUMBER P102 1-HYDROXY-2-PROPYNE 1-propyn-3-ol 2-PROPYN-1-OL 2-PROPYNOL 2-PROPYNYL ALCOHOL 3-HYDROXY-1-PROPYNE 3-PROPYNOL



IRIS Home Page Substance File List
Comments on the IRIS web site Search the IRIS database National Center for Environmental Assessment Office of Research and Development's Home Page EPA's Home Page


Last updated: 5 May 1998
URL: http://www.epa.gov/iris/SUBST/0468.HTM